Len Schleifer, Regeneron CEO (Lev Radin/Sipa USA/Sipa via AP Images)
August 9, 2023 11:18 AM EDTUpdated 12:25 PM
Deals
Cell/Gene Tx

Re­gen­eron to buy gene ther­a­py biotech Deci­bel Ther­a­peu­tics in small $109M deal

Lei Lei Wu

News Reporter

Re­gen­eron is buy­ing Deci­bel Ther­a­peu­tics and its hear­ing loss gene ther­a­pies for a mod­est $109 mil­lion, the com­pa­nies an­nounced Wednes­day morn­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times